ArticleMethods in molecular biology (Clifton, N.J.)2026
Unlocking Enzyme Discovery: Leveraging Multi-Omics, Machine Learning, and De Novo Design.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enzymes are fundamental protein catalysts essential to life processes and widely applied in industrial and healthcare sectors. However, the broader application of natural enzymes is constrained by their inherent catalytic limitations, and traditional discovery methods such as microbial enrichment are often slow and low-throughput. Driven by advances in multi-omics and artificial intelligence, a range of novel screening strategies has been developed, enabling significant enhancements in both catalytic efficiency and stability of enzymes. This chapter assesses high-throughput approaches, such as metagenomics, metaproteomics, machine learning, and de novo design, comparing their respective advantages and limitations for enzyme discovery. Furthermore, we discuss the application potential of lignocellulose-degrading and plastic-degrading enzymes in biomass conversion and plastic waste recycling.
Indexed as
Identifiers
42108294What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.